高胆固醇血症-话题@MedSci

#高胆固醇血症#

117篇内容 | 1697人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1380099, encodeId=cb611380099f8, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=JAHA：高胆固醇血症患者贝派地酸的疗效和安全性, objectType=article, longId=197927, objectId=a35c19e9276c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a35c19e9276c, replyNumber=0, likeNumber=35, createdTime=2020-07-24, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a35c19e9276c, moduleTitle=JAHA：高胆固醇血症患者贝派地酸的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a35c19e9276c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380098, encodeId=4ecd1380098fa, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=JACC：阿利昔单抗对纯合子家族性高胆固醇血症患者的疗效研究, objectType=article, longId=197277, objectId=5d5519e2775c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d5519e2775c, replyNumber=0, likeNumber=38, createdTime=2020-07-11, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d5519e2775c, moduleTitle=JACC：阿利昔单抗对纯合子家族性高胆固醇血症患者的疗效研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d5519e2775c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380097, encodeId=2bdb138009e87, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=J INTERN MED：高胆固醇血症患者他汀类药物暴露与痴呆风险, objectType=article, longId=196498, objectId=0078196498a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0078196498a0, replyNumber=0, likeNumber=41, createdTime=2020-06-27, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0078196498a0, moduleTitle=J INTERN MED：高胆固醇血症患者他汀类药物暴露与痴呆风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0078196498a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380100, encodeId=6fc2138010039, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=Circulation：家族性高胆固醇血症的全球发病率, objectType=article, longId=195931, objectId=03e21959319e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03e21959319e, replyNumber=0, likeNumber=32, createdTime=2020-06-17, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03e21959319e, moduleTitle=Circulation：家族性高胆固醇血症的全球发病率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03e21959319e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380096, encodeId=cf16138009676, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=JACC：脂蛋白与家族性高胆固醇血症的相关性研究, objectType=article, longId=195117, objectId=6fb019511e09, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6fb019511e09, replyNumber=0, likeNumber=41, createdTime=2020-06-03, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6fb019511e09, moduleTitle=JACC：脂蛋白与家族性高胆固醇血症的相关性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6fb019511e09)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380095, encodeId=7888138009578, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=JACC：家族性高胆固醇血症的全球流行病学研究, objectType=article, longId=194709, objectId=faf2194e09d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=faf2194e09d6, replyNumber=0, likeNumber=0, createdTime=2020-05-27, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=faf2194e09d6, moduleTitle=JACC：家族性高胆固醇血症的全球流行病学研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=faf2194e09d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380094, encodeId=0509138009458, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=NEJM：Inclisiran用于治疗家族性高胆固醇血症, objectType=article, longId=192408, objectId=44b9192408bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44b9192408bf, replyNumber=0, likeNumber=0, createdTime=2020-04-18, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44b9192408bf, moduleTitle=NEJM：Inclisiran用于治疗家族性高胆固醇血症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44b9192408bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380093, encodeId=cb9e138009361, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=Esperion的非他汀类口服片剂NILEMDO，获欧洲批准治疗高胆固醇血症和混合性血脂异常, objectType=article, longId=191678, objectId=efac1916e828, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=efac1916e828, replyNumber=0, likeNumber=39, createdTime=2020-04-09, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=efac1916e828, moduleTitle=Esperion的非他汀类口服片剂NILEMDO，获欧洲批准治疗高胆固醇血症和混合性血脂异常, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=efac1916e828)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380092, encodeId=c4ec1380092fe, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=NEJM：Inclisiran治疗家族性高胆固醇血症, objectType=article, longId=190423, objectId=88ff190423ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88ff190423ea, replyNumber=0, likeNumber=34, createdTime=2020-03-21, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88ff190423ea, moduleTitle=NEJM：Inclisiran治疗家族性高胆固醇血症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88ff190423ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380091, encodeId=d75e13800914e, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=JACC：evolocumab治疗家族性高胆固醇血症的远期预后研究, objectType=article, longId=188539, objectId=848d188539d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=848d188539d4, replyNumber=0, likeNumber=44, createdTime=2020-02-23, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=848d188539d4, moduleTitle=JACC：evolocumab治疗家族性高胆固醇血症的远期预后研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=848d188539d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380090, encodeId=089b1380090b6, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=Circulation：CRISPR/Cas9基因编辑或可用于治疗LDLR突变型家族性高胆固醇血症, objectType=article, longId=185698, objectId=7e00185698b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e00185698b8, replyNumber=0, likeNumber=31, createdTime=2020-01-06, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e00185698b8, moduleTitle=Circulation：CRISPR/Cas9基因编辑或可用于治疗LDLR突变型家族性高胆固醇血症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e00185698b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380089, encodeId=d3a4138008916, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=Circulation刊发中国专家新发现：基因编辑阻断高胆固醇血症家族遗传, objectType=article, longId=184808, objectId=7a53184808ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a53184808ad, replyNumber=0, likeNumber=33, createdTime=2019-12-17, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a53184808ad, moduleTitle=Circulation刊发中国专家新发现：基因编辑阻断高胆固醇血症家族遗传, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a53184808ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380088, encodeId=c607138008816, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=Circulation：中国专家研究新发现，基因编辑阻断高胆固醇血症家族遗传, objectType=article, longId=184367, objectId=ae1718436e9f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae1718436e9f, replyNumber=0, likeNumber=36, createdTime=2019-12-08, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae1718436e9f, moduleTitle=Circulation：中国专家研究新发现，基因编辑阻断高胆固醇血症家族遗传, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae1718436e9f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380087, encodeId=1409138008ed4, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=Clin Chem：脂蛋白(a)在家族性高胆固醇血症诊断中的作用?, objectType=article, longId=181844, objectId=0c51181844fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c51181844fc, replyNumber=0, likeNumber=51, createdTime=2019-10-25, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c51181844fc, moduleTitle=Clin Chem：脂蛋白(a)在家族性高胆固醇血症诊断中的作用?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c51181844fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380086, encodeId=363b13800863d, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=NEJM：他汀类药物对儿童家族性高胆固醇血症的长期影响, objectType=article, longId=181486, objectId=5afe181486e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5afe181486e6, replyNumber=0, likeNumber=25, createdTime=2019-10-19, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5afe181486e6, moduleTitle=NEJM：他汀类药物对儿童家族性高胆固醇血症的长期影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5afe181486e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380085, encodeId=ca99138008509, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=Regeneron的ANGPTL3单抗evinacumab治疗家族性高胆固醇血症的III期临床成功, objectType=article, longId=177716, objectId=cb201e7716eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb201e7716eb, replyNumber=0, likeNumber=41, createdTime=2019-08-17, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb201e7716eb, moduleTitle=Regeneron的ANGPTL3单抗evinacumab治疗家族性高胆固醇血症的III期临床成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb201e7716eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380084, encodeId=a545138008416, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=JACC：单基因vs多基因家族性高胆固醇血症患者的心血管风险研究, objectType=article, longId=176430, objectId=867b1e6430e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=867b1e6430e4, replyNumber=0, likeNumber=30, createdTime=2019-07-31, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=867b1e6430e4, moduleTitle=JACC：单基因vs多基因家族性高胆固醇血症患者的心血管风险研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=867b1e6430e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380083, encodeId=96df1380083d4, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=JACC：每10位年轻心梗患者就有1人为家族性高胆固醇血症，心梗前四成人没用他汀, objectType=article, longId=166997, objectId=587b16699eea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=587b16699eea, replyNumber=0, likeNumber=34, createdTime=2019-05-29, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=587b16699eea, moduleTitle=JACC：每10位年轻心梗患者就有1人为家族性高胆固醇血症，心梗前四成人没用他汀, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=587b16699eea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380082, encodeId=f19a138008204, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=JACC：家族性高胆固醇血症在年轻心梗患者中常见, objectType=article, longId=166551, objectId=fd3316655156, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd3316655156, replyNumber=0, likeNumber=46, createdTime=2019-05-23, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd3316655156, moduleTitle=JACC：家族性高胆固醇血症在年轻心梗患者中常见, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd3316655156)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380081, encodeId=ae731380081e0, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=Gastroenterology：人群中高胆固醇血症和他汀类药物暴露对肝硬化患者生存的影响, objectType=article, longId=166289, objectId=46b31662896d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46b31662896d, replyNumber=0, likeNumber=40, createdTime=2019-05-19, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46b31662896d, moduleTitle=Gastroenterology：人群中高胆固醇血症和他汀类药物暴露对肝硬化患者生存的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=46b31662896d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

高胆固醇血症

2020-05-29

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

JAHA：高胆固醇血症患者贝派地酸的疗效和安全性

2020-07-24

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

JACC：阿利昔单抗对纯合子家族性高胆固醇血症患者的疗效研究

2020-07-11

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

J INTERN MED：高胆固醇血症患者他汀类药物暴露与痴呆风险

2020-06-27

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

Circulation：家族性高胆固醇血症的全球发病率

2020-06-17

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

JACC：脂蛋白与家族性高胆固醇血症的相关性研究

2020-06-03

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

JACC：家族性高胆固醇血症的全球流行病学研究

2020-05-27

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

NEJM：Inclisiran用于治疗家族性高胆固醇血症

2020-04-18

hb2008ye (审核中...)

前往app查看评论内容

#高胆固醇血症#

Esperion的非他汀类口服片剂NILEMDO，获欧洲批准治疗高胆固醇血症和混合性血脂异常

2020-04-09

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

NEJM：Inclisiran治疗家族性高胆固醇血症

2020-03-21

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

JACC：evolocumab治疗家族性高胆固醇血症的远期预后研究

2020-02-23

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

Circulation：CRISPR/Cas9基因编辑或可用于治疗LDLR突变型家族性高胆固醇血症

2020-01-06

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

Circulation刊发中国专家新发现：基因编辑阻断高胆固醇血症家族遗传

2019-12-17

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

Circulation：中国专家研究新发现，基因编辑阻断高胆固醇血症家族遗传

2019-12-08

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

Clin Chem：脂蛋白(a)在家族性高胆固醇血症诊断中的作用?

2019-10-25

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

NEJM：他汀类药物对儿童家族性高胆固醇血症的长期影响

2019-10-19

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

Regeneron的ANGPTL3单抗evinacumab治疗家族性高胆固醇血症的III期临床成功

2019-08-17

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

JACC：单基因vs多基因家族性高胆固醇血症患者的心血管风险研究

2019-07-31

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

JACC：每10位年轻心梗患者就有1人为家族性高胆固醇血症，心梗前四成人没用他汀

2019-05-29

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

JACC：家族性高胆固醇血症在年轻心梗患者中常见

2019-05-23

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

Gastroenterology：人群中高胆固醇血症和他汀类药物暴露对肝硬化患者生存的影响

2019-05-19

科室
- - 订阅+
  - 更多科室
工具
服务